A Descriptive Review of Cannabis sativa Patents for Cancer Treatment

Isabela Fernandes Pereira1, Ana Maria Santos Oliveira2, Anamaria Mendonça Santos3

  • 1Faculty of Pharmacy, Federal University of Bahia, Campus Ondina, Salvador, BA, Brazil.

Abstract

Insights

This patent review reveals a growing interest in cannabis-based cancer treatments. Research highlights tetrahydrocannabinol and cannabidiol as key compounds driving innovation in new cancer medicines.

Area of Science:

  • Oncology
  • Pharmacology
  • Intellectual Property Law

Background:

  • Cannabis compounds are being investigated for their potential in cancer treatment and tumor remission.
  • The discovery of endogenous cannabinoids has spurred research into cannabis-based therapies.

Approach:

  • A critical patent review was conducted using the Espacenet database.
  • Search terms included "cancer" and "Cannabis or cannabidiol" in titles or abstracts.
  • 21 relevant patents were selected after excluding duplicates and irrelevant studies.

Key Points:

  • Pharmaceutical industries and researchers show increasing interest in cannabis for cancer.
  • Tetrahydrocannabinol (THC), cannabidiol (CBD), and hemp are the primary cannabinoids in reviewed patents.
  • The United States and Japan lead in patent filings, with a surge in 2019, primarily from industry.

Conclusions:

  • Parliamentary approval for cannabis cultivation and investment is crucial for innovation.
  • Increased investment fosters advancements in cannabis research for novel cancer medicines.
  • This research contributes to the development of new therapeutic strategies in oncology.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
351
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K